Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response
- PMID: 3105135
Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response
Similar articles
-
Overview of the development of Orthoclone OKT3: monoclonal antibody for therapeutic use in transplantation.Transplant Proc. 1987 Apr;19(2 Suppl 1):1-6. Transplant Proc. 1987. PMID: 3105134 Review. No abstract available.
-
Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.Transplantation. 1986 May;41(5):572-8. doi: 10.1097/00007890-198605000-00004. Transplantation. 1986. PMID: 3085297
-
Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies.Clin Lab Med. 1991 Sep;11(3):693-714. Clin Lab Med. 1991. PMID: 1934971 Review.
-
In vivo use of OKT3: main issues for the monitoring of treated patients.Transplant Proc. 1990 Dec;22(6):2605-8. Transplant Proc. 1990. PMID: 2124743 No abstract available.
-
In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment.Transplant Proc. 1990 Aug;22(4):1782. Transplant Proc. 1990. PMID: 2143860 No abstract available.
Cited by
-
New peptide and protein drugs.Pharm World Sci. 1996 Jun;18(3):87-93. doi: 10.1007/BF00417755. Pharm World Sci. 1996. PMID: 8826532 Review.
-
Morphology of rat kidney and thymus after native and antibody-coupled cyclosporin A application (reduced toxicity of targeted drug).Folia Microbiol (Praha). 1997;42(3):277-87. doi: 10.1007/BF02819003. Folia Microbiol (Praha). 1997. PMID: 9246765
-
Interference in thyrotropin (TSH) determination: falsely elevated TSH values in a transplanted patient.Eur J Nucl Med. 1989;15(4):194-6. doi: 10.1007/BF00253793. Eur J Nucl Med. 1989. PMID: 2502414